Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Salestools Logo

Salestools

El agente IA #1 para equipos de ventas y Go-to-Market. Vende más, más rápido, con menos esfuerzo.

Producto

  • Agentes de ventas IA
  • Datos de intención
  • Datos tecnológicos
  • Seguimiento de visitantes
  • Co-Pilot
  • Venta social

Soluciones

  • Servicio al cliente
  • Comercio electrónico
  • SaaS
  • Empresarial
  • Pequeña empresa

Recursos

  • El informe
  • Documentación
  • Referencia de API
  • Centro de ayuda
  • Blog
  • Casos de estudio
  • Webinars

Empresa

  • Acerca de
  • Carreras
  • Prensa
  • Contacto
  • Socios

Nuestras ubicaciones

  • Nueva York, HQ
  • Bucarest, laboratorio de investigación IA
  • Zug, Suiza

© 2026 Salestools. Todos los derechos reservados.

Términos de datos y seguridadPolítica de privacidadTérminos de servicioAcceptable Use
Todos los sistemas operativos
Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Back to Reports
Biotech

Caris Life Sciences

Caris Life Sciences raises $168M Growth at $1.9B valuation

Irving, TXOctober 6, 20251 min read
Total Raised
$168M
Valuation
$1.9B
Latest Round
Growth
Employees
1000+

Caris Life Sciences: Growth Funding Round

Caris Life Sciences has successfully raised $168M in Growth funding, reaching a valuation of $1.9B.

Company Overview

Molecular profiling and AI/ML for precision medicine development

Funding Details

The Growth round was led by Braidwell.

Company Information

  • Headquarters: Irving, TX
  • Founded: 2018
  • Employees: 1000+
  • Category: Biotech

Investment

Caris Life Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Braidwell: Verified investor in Growth

Company Info

Headquarters
Irving, TX
Founded
2018
Team Size
1000+
Last Round
$168M(Oct 2025)

Investors (1)

B
BraidwellLead
Lead Investor
Verified investor in Growth

Topics

verified(3079)real-funding(3079)caris-life-sciencesbiotechgrowthirving

Share

Related Reports

Biotech
AusperBio

AusperBio Raises $73M Series B

Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials

David Chen
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics

Orna Therapeutics Raises $251M Series B

Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases

Emma Rodriguez
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics

Forge Biologics Raises $120M Series C

Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines

Sarah Kim
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free